About: Potential drug‐drug interactions associated with drugs currently proposed for COVID‐19 treatment in patients receiving other treatments

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Potential drug‐drug interactions associated with drugs currently proposed for COVID‐19 treatment in patients receiving other treatments Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Potential drug‐drug interactions associated with drugs currently proposed for COVID‐19 treatment in patients receiving other treatments
Creator	Tod, Michel Solas, Caroline Lemaitre, Florian Barin-Le Guellec, Chantal Elens, Laure Grégoire, Matthieu Lagarce, Laurence Polard, Elisabeth Saint-Salvi, Béatrice Sommet, Agnès
Source	Medline; PMC
abstract	Patients with COVID‐19 are sometimes already being treated for one or more other chronic conditions, especially if they are elderly. Introducing a treatment against COVID‐19, either on an outpatient basis or during hospitalization for more severe cases, raises the question of potential drug‐drug interactions. Here, we analyzed the potential or proven risk of the co‐administration of drugs used for the most common chronic diseases and those currently offered as treatment or undergoing therapeutic trials for COVID‐19. Practical recommendations are offered, where possible.
has issue date	2020-06-30(xsd:dateTime)
bibo:doi	10.1111/fcp.12586
bibo:pmid	32603486
has license	no-cc
sha1sum (hex)	8c918d33eac601b6e2ecda8b28fb04f9f68ef34a
schema:url	https://doi.org/10.1111/fcp.12586
resource representing a document's title	Potential drug‐drug interactions associated with drugs currently proposed for COVID‐19 treatment in patients receiving other treatments
has PubMed Central identifier	PMC7361515
has PubMed identifier	32603486
schema:publication	Fundam Clin Pharmacol
resource representing a document's body	covid:8c918d33eac601b6e2ecda8b28fb04f9f68ef34a#body_text
is schema:about of	named entity 'elderly' named entity 'COVID-19' named entity 'CONDITIONS' named entity 'OFFERED' named entity 'TREATMENT' named entity 'COMMON' named entity 'chronic conditions' named entity 'drugs' named entity 'outpatient' named entity 'drug-drug interactions' named entity 'drug-drug interactions' named entity 'diuretics' named entity 'IL-6' named entity 'aspirin' named entity 'Macrolide antibiotics' named entity 'toxicity' named entity 'corticosteroids' named entity 'cardiotoxicity' named entity 'drug interactions' named entity 'SARS-CoV-2' named entity 'Cisatracurium' named entity 'phosphorylated' named entity 'intensive care units' named entity 'spironolactone' named entity 'volume of distribution' named entity 'type 2 diabetes' named entity 'inflammation' named entity 'SARS-CoV-2' named entity 'Baricitinib' named entity 'CYP3A4' named entity 'membrane receptors' named entity 'drug-drug interactions' named entity 'enzyme-inducing' named entity 'cocaine' named entity 'infection control' named entity 'Lopinavir' named entity 'lopinavir' named entity 'drug-drug interactions' named entity 'dexmedetomidine' named entity 'COVID-19' named entity 'Severe acute respiratory syndrome coronavirus 2' named entity 'downregulation' named entity 'CYP3A4' named entity 'metabolism' named entity 'resuscitation' named entity 'lopinavir' named entity 'virions' named entity 'voxilaprevir' named entity 'glimepiride' named entity 'hydroxychloroquine' named entity 'CYP3A4' named entity 'hydroxychloroquine' named entity 'drug-drug interaction' named entity 'remdesivir' named entity 'antivirals' named entity 'CYP3A4' named entity 'CYP3A4' named entity 'sirolimus' named entity 'morphine-6-glucuronide' named entity 'pimozide' named entity 'CYP3A4' named entity 'antiretroviral treatment' named entity 'China' named entity 'phenytoin' named entity 'lopinavir' named entity 'metabolized' named entity 'tacrolimus' named entity 'lopinavir' named entity 'hydroxychloroquine' named entity 'lopinavir' named entity 'azithromycin' named entity 'lopinavir'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software